Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDA | P32320 | 9/20 | 0.55 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.44 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.44 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.44 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | PYGM | P11217 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29180738 | 0.89 | CDA (0.54) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL10859054 | 0.86 | CDA (0.52) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL7705298 | 0.86 | CDA (0.54) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| Uridine SCHEMBL29002276 | 0.84 | SLC28A1 (0.73) | SLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL7452167 | 0.82 | CDA (0.49) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL7452161 | 0.82 | CDA (0.49) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL399314 | 0.78 | CDA (0.66) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL18512836 | 0.78 | CDA (0.66) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL6015184 | 0.78 | CDA (0.66) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL30241991 | 0.78 | CDA (0.66) | CDASLC28A1SLC28A2SLC29A1SLC28A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121586719-A | Conjugate compositions comprising guanidine phosphate linkages and uses thereof | 艾维迪提生物科学公司 | 2026-02-27 | — | — | CN | disclosed |
| CN-120158444-A | Negative selection method and system for purifying circular nucleic acid | 上海环码生物医药有限公司 | 2025-06-17 | — | — | CN | disclosed |
| CN-120082543-A | Negative selection method and system for purifying circular nucleic acid | 上海环码生物医药有限公司 | 2025-06-03 | — | — | CN | disclosed |
| CN-119365597-A | Antibody oligonucleotide conjugate compositions and methods for inducing DMD exon 44 skipping | 艾维迪提生物科学公司 | 2025-01-24 | — | — | CN | disclosed |
| CN-118662652-A | Nucleic acid-polypeptide compositions and uses thereof | 艾维迪提生物科学公司 | 2024-09-20 | — | — | CN | disclosed |
| CN-118267396-A | Nucleic acid-polypeptide compositions and uses thereof | 艾维迪提生物科学公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-118019527-A | Method for preparing lipid nanoparticle compositions | 摩登纳特斯有限公司 | 2024-05-10 | — | — | CN | disclosed |
| CN-118019526-A | Methods for preparing lipid nanoparticle compositions for delivery of payload molecules to airway epithelium | 摩登纳特斯有限公司 | 2024-05-10 | — | — | CN | disclosed |
| CN-114728886-B | Lipid compounds and compositions containing carbonates for intracellular delivery of therapeutic agents | 摩登纳特斯有限公司 | 2024-04-12 | — | — | CN | disclosed |
| CN-111655268-B | Nucleic acid-polypeptide compositions and uses thereof | 艾维迪提生物科学公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-117615752-A | RNA compositions comprising buffer substances and methods of making, storing, and using the same | 生物技术欧洲股份公司 | 2024-02-27 | — | — | CN | disclosed |
| CN-109715805-B | Nucleic acid-polypeptide compositions and uses thereof | 艾维迪提生物科学公司 | 2024-01-05 | — | — | CN | disclosed |
| CN-116916896-A | Method for preparing lipid nanoparticles | 摩登纳特斯有限公司 | 2023-10-20 | — | — | CN | disclosed |
| CN-116157520-A | Compositions and methods for genome editing | 塑造治疗公司 | 2023-05-23 | — | — | CN | disclosed |